ICD-10-CM Billable Code

C7A.025

Malignant carcinoid tumor of the sigmoid colon

Clinical Classification Guidelines

Medical Intelligence & Overview

A malignant carcinoid tumor located in the sigmoid colon is a rare type of neuroendocrine cancer that originates in the hormone-producing cells of the digestive tract. The sigmoid colon, which is the S-shaped portion of the large intestine located near the rectum, can develop these tumors, though it is uncommon. Early detection and treatment are critical for improving outcomes, but because symptoms can be subtle or absent in early stages, medical evaluation is essential for diagnosis.

Causes & Symptoms

Clinical Causes: Genetic predisposition or inherited syndromes Chronic inflammation of the colon, such as inflammatory bowel disease Dietary factors that influence gut health Unknown environmental exposures Age-related changes, as these tumors are more common in older adults

Key Symptoms: Changes in bowel habits, such as diarrhea or constipation Rectal bleeding or blood in the stool Abdominal pain or discomfort Unexplained weight loss Feeling of fullness or bloating in the abdomen Nausea or vomiting in some cases Signs of hormone secretion, like flushing or diarrhea (if the tumor secretes hormones)

Diagnostic & Treatment

Diagnosis Path: Diagnosing a carcinoid tumor in the sigmoid colon involves a combination of medical history, physical examination, and specialized tests. Procedures and tests may include:

Treatment Protocols: Treatment options depend on the tumor's size, location, spread, and hormonal activity. Common approaches include:

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C7A.025 a billable ICD-10 code?
Yes, C7A.025 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C7A.025?
Clinical documentation must specify the nature of Malignant carcinoid tumor of the sigmoid colon and any associated comorbidities for accurate reporting.

Cite this Clinical Reference